YingLiang Wu

InstitutionShenyang Pharmaceutical University
AddressShenyang
Liaoning
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in January 2020
    All Publications
    Bar chart showing 159 publications over 18 distinct years, with a maximum of 20 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sun F, Mu C, Kwok HF, Xu J, Wu Y, Liu W, Sabatier JM, Annweiler C, Li X, Cao Z, Xie Y. Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19. Int J Biol Sci. 2021; 17(9):2348-2355. PMID: 34239361.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    2. Cheng Y, Sun F, Wang L, Gao M, Xie Y, Sun Y, Liu H, Yuan Y, Yi W, Huang Z, Yan H, Peng K, Wu Y, Cao Z. Virus-induced p38 MAPK activation facilitates viral infection. Theranostics. 2020; 10(26):12223-12240. PMID: 33204339.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    3. Annweiler C, Bourgeais A, Faucon E, Cao Z, Wu Y, Sabatier JM. Neurological, Cognitive, and Behavioral Disorders during COVID-19: The Nitric Oxide Track. J Am Geriatr Soc. 2020 09; 68(9):1922-1923. PMID: 32583434.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    4. Cao Z, Wu Y, Faucon E, Sabatier JM. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments. Infect Disord Drug Targets. 2020; 20(3):348-349. PMID: 32370727.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    5. Annweiler C, Cao Z, Wu Y, Faucon E, Mouhat S, Kovacic H, Sabatier JM. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients. Infect Disord Drug Targets. 2020; 20(4):407-408. PMID: 32418532.
      Citations: 22     Fields:    Translation:HumansPHPublic Health
    6. Chen Y, Tao J, Sun Y, Wu A, Su C, Gao G, Cai H, Qiu S, Wu Y, Ahola T, Guo D. Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase. J Virol. 2013 Jun; 87(11):6296-305. PMID: 23536667.
      Citations: 35     Fields:    Translation:Cells
    7. Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y, Yan H, Li W. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Peptides. 2011 Jul; 32(7):1518-25. PMID: 21620914.
      Citations: 42     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    8. Sha Y, Wu Y, Cao Z, Xu X, Wu W, Jiang D, Mao X, Liu H, Zhu Y, Gong R, Li W. A convenient cell fusion assay for the study of SARS-CoV entry and inhibition. IUBMB Life. 2006 Aug; 58(8):480-6. PMID: 16916786.
      Citations: 3     Fields:    Translation:AnimalsCells